Similar to results seen with cell lines (data not shown), treatment of primary AML samples with etoposide resulted in decreased numbers of CyclinA2+ cells available for analysis and induced DNA damage (p-H2AX) in both CyclinA2- and CyclinA2+ AML cell subsets (Figure 7). This evidence concerns the gene H2AX and acute myeloid leukemia.